Culler, Kasen L.
Sinha, Arjun
Filipp, Mallory
Giro, Pedro
Allen, Norrina B.
Taylor, Kent D.
Guo, Xiuqing
Thorp, Ed
Freed, Benjamin H.
Greenland, Philip
Post, Wendy S.
Bertoni, Alain
Herrington, David
Gao, Chen
Wang, Yibin
Shah, Sanjiv J.
Patel, Ravi B.
Article History
Received: 21 May 2024
Accepted: 27 August 2024
First Online: 5 September 2024
Competing interests
: S.J.S. has received research grants from AstraZeneca, Corvia, and Pfizer, and consulting fees from Abbott, Alleviant, AstraZeneca, Amgen, Aria CV, Axon Therapies, Bayer, Boehringer-Ingelheim, Boston Scientific, Bristol Myers Squibb, Cyclerion, Cytokinetics, Edwards Lifesciences, Eidos, Imara, Impulse Dynamics, Intellia, Ionis, Lilly, Merck, MyoKardia, Novartis, Novo Nordisk, Pfizer, Prothena, Regeneron, Rivus, Sardocor, Shifamed, Tenax, Tenaya, and Ultromics. The authors declare no competing interests.